F 
85.20
+5.03%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$785.0m
FY2016FY2025
Net income
$54.4m
FY2016FY2025
Free cash flow
$11.7m
FY2016FY2025
Shareholders' equity
$1.04bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $785.0m | $763.6m | $663.1m | $747.9m | $769.7m | $693.6m | $589.5m | $529.7m | $548.4m | $383.9m |
| Gross profit | $307.2m | $307.9m | $258.6m | $296.0m | $322.8m | $287.9m | $237.5m | $210.3m | $215.6m | $102.7m |
| Research and development | $115.9m | $121.9m | $115.8m | $109.2m | $100.9m | $89.0m | $81.5m | $75.0m | $73.8m | $57.5m |
| Operating income | $64.2m | $64.8m | $82.8m | $54.9m | $98.1m | $83.8m | $49.7m | $36.1m | $46.3m | −$47.9m |
| Net income | $54.4m | $69.6m | $82.4m | $50.7m | $83.9m | $78.5m | $39.3m | $104.0m | $40.9m | −$6.6m |
| Diluted earnings per share | 0.69 | 0.89 | 1.05 | 0.66 | 1.06 | 0.99 | 0.50 | 1.38 | 0.55 | -0.09 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.22bn | $1.15bn | $1.11bn | $1.01bn | $1.02bn | $963.2m | $839.9m | $728.2m | $646.6m | $620.0m |
| Cash and short-term investments | $276.2m | $360.0m | $328.3m | $238.1m | $276.1m | $255.0m | $220.9m | $149.0m | $140.2m | $108.9m |
| Total liabilities | $189.0m | $198.4m | $198.0m | $199.9m | $204.7m | $219.1m | $198.9m | $148.1m | $187.9m | $218.9m |
| Debt | $19.9m | $21.7m | $22.8m | $15.4m | $32.3m | $41.2m | $65.0m | $64.8m | $105.7m | $138.2m |
| Shareholders' equity | $1.04bn | $947.8m | $908.8m | $808.3m | $815.8m | $744.1m | $641.0m | $580.2m | $458.6m | $401.1m |
| Shares outstanding | 79m | 78m | 78m | 77m | 79m | 80m | 78m | 75m | 75m | 71m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $115.4m | $117.5m | $64.6m | $131.8m | $139.4m | $169.3m | $121.0m | $68.7m | $86.3m | $17.4m |
| Capital spending | −$103.7m | −$38.4m | −$56.0m | −$65.3m | −$66.5m | −$55.9m | −$20.8m | −$19.9m | −$17.8m | −$11.5m |
| Free cash flow | $11.7m | $79.1m | $8.6m | $66.5m | $72.9m | $113.4m | $100.2m | $48.8m | $68.6m | $5.9m |
| Dividends paid | — | — | −$1 | — | — | −$15.4m | −$8.0m | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $258.2m | $226.1m | $215.2m | $202.7m | $195.8m | $171.4m | $189.5m | $207.9m |
| Gross profit | $130.9m | $108.3m | $90.8m | $80.6m | $72.9m | $64.5m | $73.6m | $84.7m |
| Operating income | $57.8m | $47.1m | $25.2m | $19.0m | $12.3m | $3.3m | $7.8m | $18.0m |
| Net income | $56.2m | $20.4m | $23.2m | $15.7m | $9.1m | $6.4m | $9.7m | $19.0m |
| Diluted earnings per share | 0.71 | 0.26 | 0.29 | 0.20 | 0.12 | 0.08 | 0.12 | 0.24 |
| Cash from operations | $61.0m | $44.0m | $45.0m | $26.0m | $18.0m | $23.0m | $35.0m | $26.0m |
| Capital spending | −$9.0m | −$15.0m | −$11.0m | −$7.0m | −$66.0m | −$18.0m | −$7.0m | −$8.0m |
| Free cash flow | $52.0m | $29.0m | $34.0m | $19.0m | −$48.0m | $5.0m | $28.0m | $18.0m |
| Total assets | $1.34bn | $1.26bn | $1.22bn | $1.20bn | $1.18bn | $1.16bn | $1.15bn | $1.15bn |
| Cash and short-term investments | $345.6m | $303.3m | $275.2m | $266.0m | $249.3m | $299.0m | $360.0m | $354.5m |
| Debt | $20.0m | $20.3m | $11.1m | $11.4m | $11.6m | $11.9m | $12.0m | $12.0m |
| Shareholders' equity | $1.11bn | $1.06bn | $1.04bn | $1.01bn | $990.0m | $965.9m | $948.0m | $955.0m |
Financial ratios
Data as of 10 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 39.1% | 40.3% | 39.0% | 39.6% | 41.9% | 41.5% |
| Operating margin | 8.6% | 10.5% | 12.5% | 7.8% | 12.9% | 12.4% |
| Net margin | 6.9% | 9.1% | 12.4% | 6.8% | 10.9% | 11.3% |
| Return on equity | 5.3% | 7.3% | 9.1% | 6.3% | 10.3% | 10.6% |
| Return on assets | 4.4% | 6.1% | 7.4% | 5.0% | 8.2% | 8.2% |
| Free cash flow yield | 2.0% | 1.4% | 1.1% | 1.8% | 1.9% | 2.0% |
| Revenue growth | 2.8% | 15.2% | -11.3% | -2.8% | 11.0% | 17.7% |
| Earnings growth | -21.9% | -15.5% | 62.4% | -39.5% | 6.9% | 99.6% |
| Current ratio | 4.50x | 4.61x | 4.38x | 3.17x | 3.52x | 3.15x |
| Debt to equity | 0.02x | 0.02x | 0.03x | 0.03x | 0.04x | 0.06x |
| Equity ratio | 84.6% | 82.7% | 82.1% | 80.2% | 79.9% | 77.2% |
| Interest coverage | 130.30x | 190.98x | 196.57x | 100.95x | 164.62x | 99.58x |
| R&D as a share of sales | 14.8% | 16.0% | 17.5% | 14.6% | 13.1% | 12.8% |
| Buybacks as a share of market value | -1.1% | 0.5% | -1.9% | 2.7% | 0.6% | -1.9% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 1.6% | 2.5% | 10.8% |
| Operating income | 5.4% | -5.2% | — |
| Net income | 2.3% | -7.1% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 39.7% | 39.5% | 40.3% | 39.0% |
| Operating margin | 8.3% | 9.0% | 10.1% | 7.8% |
| Net margin | 8.0% | 8.7% | 9.5% | 8.8% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 80.9 | 49.3 | 39.7 | 33.7 | 43.1 | 43.6 | 51.5 | 10.2 | 28.6 | -121.0 |
| Price to sales | 5.6 | 4.5 | 4.9 | 2.3 | 4.7 | 4.9 | 3.4 | 2.0 | 2.1 | 2.1 |
Market value over time
30 Nov 2016 to 9 Oct 2026, in USD
$789.6m$11.11bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 23% | 11% | 78% | -45% | -4% | 64% | 92% | -19% | 39% | 39% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.